CPRIT Awards Research Grant to TTUHSC’s Reynolds

Funds to Aid Childhood, Adolescent Cancer Study

C Patrick Reylonds MD PhD

The Cancer Prevention and Research Institute of Texas (CPRIT) in February announced a $1,196,214 grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center (TTUHSC).

The grant, “GD2 Expression and Response to Chemoimmunotherapy in Neuroblastoma,” will provide funding for Reynolds’ ongoing investigations into the way cancer cells escape from therapy with antibodies that bind to GD2, for which preliminary data suggest the mechanism is loss of GD2 from the cancer cells. Dinutuximab, an antibody binding to GD2, can enhance chemoimmunotherapy both in patients and in preclinical models.

Neuroblastoma is the most common cancer outside of the brain in infants and young children and is challenging to treat, especially in patients that relapse after initial therapy. GD2 is a complex molecule highly expressed on neuroblastoma cells and is a target for successfully treating tumors.

“Children with cancer, both in Texas and beyond are fortunate that CPRIT has made funding childhood cancer a priority,” Reynolds said. “This recent grant from CPRIT will enable us to understand how tumor cells escape therapy with an antibody that is effective at treating neuroblastoma. The grant also supports our laboratory here at TTUHSC in analyzing clinical samples from across the U.S. and Canada from patients with neuroblastoma to assess the amount of antibody that binds to their tumor cells.”

Reynolds, a University Distinguished Professor, also directs the South Plains Cancer Consortium and the Childhood Oncology Group Childhood Cancer Repository, powered by Alex’s Lemonade Stand Foundation. The repository, based at TTUHSC, collects, preserves and distributes validated childhood cancer cell lines to researchers around the world who are investigating childhood cancer.

Related Stories

Molecular Pathology Preceptorship: Unmatched Value and Experience

Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.

Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.

TTUHSC School of Nursing to Celebrate New YWCA Location

Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.

Recent Stories

Research

Study Focuses on Resistance to Androgen Receptor-Targeted Therapy in Advanced Prostate Cancer

A TTUHSC research team led by Srinivas Nandana, Ph.D., and Manisha Tripathi, Ph.D., from the TTUHSC School of Medicine recently completed a study that focused on uncovering the mechanisms that drive the progression of prostate cancer.

Education

Medical Students Meet Their Match

March represents springtime, new beginnings and time for Match Day for fourth-year medical students nationwide. The Texas Tech University Health Sciences Center’s (TTUHSC) School of Medicine students participated in Match Day Friday (March 21).

Health

Burnout and Compassion Fatigue: Health and Human Services

Dr. Elizabeth Chavez-Palacios, LPC-S, CRC, instructor for the Clinical Rehabilitation Counseling program at TTUHSC, discussed burnout and compassion fatigue.